Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabet Clua

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Journal of Perinatal Medicine|May 4, 2011
Prevention of prematurity by single embryo transferPedro N Barri, Buenaventura Coroleu, Elisabet Clua, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|July 6, 2011
Replacing GnRH agonists with GnRH antagonists in oocyte recipient cycle did not adversely affect the pregnancy ratesFrancisca Martínez, Laura Latre, Elisabet Clua, et al.
Human Reproduction (Oxford, England)|October 21, 2022
Comparison of blastocyst euploidy rates following luteal versus follicular phase stimulation in a GnRH antagonist protocol: a prospective study with repeated ovarian stimulation cyclesFrancisca Martinez, Elisabet Clua, Marta Roca, et al.
Reproductive Biomedicine Online|March 6, 2022
Recipient outcomes in an oocyte donation programme: should very young donors be excluded?Marta Roca-Feliu, Elisabet Clua, Sandra García, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|April 3, 2008
Prospective, randomized, comparative study of leuprorelin + human menopausal gonadotropins versus ganirelix + recombinant follicle-stimulating hormone in oocyte donors and pregnancy rates among the corresponding recipientsFrancisca Martínez, Elisabet Clua, Nuria Parera, et al.
International Journal of Fertility & Sterility|July 19, 2020
Cross-Border Reproductive Care: Psychological Distress in A Sample of Women Undergoing <i>In Vitro</i> Fertilization Treatment with and without Oocyte DonationGracia Lasheras, Gemma Mestre-Bach, Elisabet Clua, et al.
Reproductive Biomedicine Online|November 26, 2013
Investigations into implantation failure in oocyte-donation recipientsPedro N Barri, Buenaventura Coroleu, Elisabet Clua, et al.
Reproductive Biomedicine Online|October 1, 2010
Analysis of factors associated with multiple pregnancy in an oocyte donation programmeElisabet Clua, Rosa Tur, Buenaventura Coroleu, et al.
Fertility and Sterility|May 24, 2011
Heterotopic pregnancy in a cross border oocyte donation patient: the importance of cooperation between centersFulvia Mancini, Elisabet Clua, Francisca Martínez, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|February 7, 2012
Triggering ovulation with 250 μg or 500 μg of r-hCG in oocyte donors treated with antagonist protocol has no effect on the number of mature oocytes retrieved: a randomized clinical trialElisabet Clua, Francisca Martínez, Rosa Tur, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Journal of Perinatal Medicine|May 4, 2011
Prevention of prematurity by single embryo transferPedro N Barri, Buenaventura Coroleu, Elisabet Clua, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|July 6, 2011
Replacing GnRH agonists with GnRH antagonists in oocyte recipient cycle did not adversely affect the pregnancy ratesFrancisca Martínez, Laura Latre, Elisabet Clua, et al.
Human Reproduction (Oxford, England)|October 21, 2022
Comparison of blastocyst euploidy rates following luteal versus follicular phase stimulation in a GnRH antagonist protocol: a prospective study with repeated ovarian stimulation cyclesFrancisca Martinez, Elisabet Clua, Marta Roca, et al.
Reproductive Biomedicine Online|March 6, 2022
Recipient outcomes in an oocyte donation programme: should very young donors be excluded?Marta Roca-Feliu, Elisabet Clua, Sandra García, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|April 3, 2008
Prospective, randomized, comparative study of leuprorelin + human menopausal gonadotropins versus ganirelix + recombinant follicle-stimulating hormone in oocyte donors and pregnancy rates among the corresponding recipientsFrancisca Martínez, Elisabet Clua, Nuria Parera, et al.
International Journal of Fertility & Sterility|July 19, 2020
Cross-Border Reproductive Care: Psychological Distress in A Sample of Women Undergoing <i>In Vitro</i> Fertilization Treatment with and without Oocyte DonationGracia Lasheras, Gemma Mestre-Bach, Elisabet Clua, et al.
Reproductive Biomedicine Online|November 26, 2013
Investigations into implantation failure in oocyte-donation recipientsPedro N Barri, Buenaventura Coroleu, Elisabet Clua, et al.
Reproductive Biomedicine Online|October 1, 2010
Analysis of factors associated with multiple pregnancy in an oocyte donation programmeElisabet Clua, Rosa Tur, Buenaventura Coroleu, et al.
Fertility and Sterility|May 24, 2011
Heterotopic pregnancy in a cross border oocyte donation patient: the importance of cooperation between centersFulvia Mancini, Elisabet Clua, Francisca Martínez, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|February 7, 2012
Triggering ovulation with 250 μg or 500 μg of r-hCG in oocyte donors treated with antagonist protocol has no effect on the number of mature oocytes retrieved: a randomized clinical trialElisabet Clua, Francisca Martínez, Rosa Tur, et al.
Pageof 3